{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T18:16:31Z","timestamp":1773252991324,"version":"3.50.1"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","funder":[{"DOI":"10.13039\/501100010724","name":"Health Systems Research Institute","doi-asserted-by":"crossref","award":["59-053"],"award-info":[{"award-number":["59-053"]}],"id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100032332","name":"Heart Association of Thailand","doi-asserted-by":"crossref","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/100032332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"abstract":"<jats:p>We examined the association of oral anticoagulants (OACs) discontinuation following a rise in HAS-BLED score among patients enrolled in a nationwide AF registry.<\/jats:p>\n                  <jats:p>We analyzed 1,030 patients from the prospective, multicenter COOL-AF registry who were receiving OACs at baseline and subsequently experienced an increase in HAS-BLED score. Patients were categorized according to OAC continuation (n\u2009=\u2009936) or discontinuation (n\u2009=\u200994) at the time of score increase. The primary composite outcome included all-cause mortality, stroke\/systemic embolism (SSE), and major bleeding. Multivariable Cox regression and propensity score matching (1:2) were performed to adjust for confounders.<\/jats:p>\n                  <jats:p>During a median follow-up of 23.7 months (IQR 13.3\u201329.9), patients who discontinued OACs had substantially higher event rates than those who continued therapy (20.2 vs. 7.9 per 100 person-years; p\u2009&lt;\u20090.001). OAC discontinuation independently associated with an increased risk of the composite endpoint (adjusted HR 2.65, 95% CI 1.75\u20134.02; p\u2009&lt;\u20090.001), all-cause mortality (aHR 3.66, 95% CI 2.25\u20135.96; p\u2009&lt;\u20090.001), and major bleeding (aHR 2.60, 95% CI 1.27\u20135.33; p\u2009=\u20090.009), without a significant difference in SSE (aHR 0.39, 95% CI 0.05\u20132.89). Findings were confirmed in the propensity-matched cohort. No significant difference in stroke\/systemic embolism was observed, potentially reflecting competing mortality risk and residual confounding inherent to the observational design.<\/jats:p>\n                  <jats:p>OAC discontinuation after a HAS-BLED score increase was associated with worse outcomes, likely reflecting residual confounding rather than a direct causal effect, and should prompt risk optimization rather than automatic cessation.<\/jats:p>","DOI":"10.1055\/a-2815-5300","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:51:27Z","timestamp":1771977087000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes of Atrial Fibrillation Patients with Increase in HAS-BLED Score and Discontinue Oral Anticoagulants"],"prefix":"10.1055","author":[{"given":"Voravut","family":"Rungpradubvong","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand"},{"name":"Cardiac Center, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"},{"name":"Medical University of Bialystok, Bialystok, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rungroj","family":"Krittayaphong","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"100786","DOI":"10.1016\/j.lanepe.2023.100786","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"D Linz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review","volume":"118","author":"E D Borre","year":"2018","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"R G Hart","year":"2007","journal-title":"Ann Intern Med"},{"issue":"12","key":"ref4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1055\/a-2434-9244","article-title":"The 2024 European Society of Cardiology Guidelines for diagnosis and management of atrial fibrillation: a viewpoint from a practicing clinician's perspective","volume":"124","author":"T Potpara","year":"2024","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref5","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1055\/a-2595-5575","article-title":"Patient care pathways and risk assessments in patients with atrial fibrillation: a comparison of Asian versus non-Asian cohorts","volume":"125","author":"H C Chang","year":"2025","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref6","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper","volume":"122","author":"D A Gorog","year":"2022","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"G Y Lip","year":"2010","journal-title":"Chest"},{"issue":"05","key":"ref8","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"R Pisters","year":"2010","journal-title":"Chest"},{"issue":"19","key":"ref9","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1161\/CIRCULATIONAHA.111.055079","article-title":"Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study","volume":"125","author":"L Friberg","year":"2012","journal-title":"Circulation"},{"issue":"04","key":"ref10","first-page":"739","article-title":"Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a \u201creal world\u201d nationwide cohort study","volume":"106","author":"J B Olesen","year":"2011","journal-title":"Thromb Haemost"},{"issue":"23","key":"ref11","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1016\/j.jacc.2013.08.1623","article-title":"The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation","volume":"62","author":"V Rold\u00e1n","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1055\/s-0038-1636534","article-title":"Incident risk factors and major bleeding in patients with atrial fibrillation treated with oral anticoagulants: a comparison of baseline, follow-up and delta HAS-BLED scores with an approach focused on modifiable bleeding risk factors","volume":"118","author":"T F Chao","year":"2018","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref13","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1055\/s-0038-1651482","article-title":"Dynamic changes of CHA2DS2-VASc score and the risk of ischaemic stroke in Asian patients with atrial fibrillation: a nationwide cohort study","volume":"118","author":"M Yoon","year":"2018","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/FJC.0000000000000750","article-title":"Should we judge stroke risk by static or dynamic risk scores? A focus on the dynamic nature of stroke and bleeding risks in patients with atrial fibrillation","volume":"74","author":"M Domek","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00392-021-01816-z","article-title":"Continuation or discontinuation of oral anticoagulants after HAS-BLED scores increase in patients with atrial fibrillation","volume":"111","author":"T F Chao","year":"2022","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/a-2325-5923","article-title":"2024 Chinese expert consensus guidelines on the diagnosis and treatment of atrial fibrillation in the elderly, endorsed by Geriatric Society of Chinese Medical Association (Cardiovascular Group) and Chinese Society of Geriatric Health Medicine (Cardiovascular Branch): executive summary","volume":"124","author":"Y Wang","year":"2024","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"T F Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12872-018-0911-4","article-title":"Risk profiles and pattern of antithrombotic use in patients with non-valvular atrial fibrillation in Thailand: a multicenter study","volume":"18","author":"R Krittayaphong","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"issue":"01","key":"ref19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"S Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"10","key":"ref20","first-page":"835","article-title":"Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients","volume":"77","author":"M J Serna","year":"2024","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"ehac544.517","DOI":"10.1093\/eurheartj\/ehac544.517","article-title":"Longitudinal changes in CHA2DS2-VASc and HAS-BLED scores are superior to baseline score values for predicting ischemic stroke and major bleeding in atrial fibrillation patients","volume":"43","author":"J M Rivera-Caravaca","year":"2022","journal-title":"Eur Heart J"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1160\/TH13-07-0556","article-title":"Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation","volume":"110","author":"P Gallego","year":"2013","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/a-2278-8769","article-title":"Racial differences in ischemic and hemorrhagic stroke: an ecological epidemiological study","volume":"124","author":"D S Kang","year":"2024","journal-title":"Thromb Haemost"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"102039","DOI":"10.1016\/j.eclinm.2023.102039","article-title":"Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry","volume":"63","author":"G F Romiti","year":"2023","journal-title":"EClinicalMedicine"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2815-5300.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T23:37:39Z","timestamp":1773185859000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2815-5300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1055\/a-2815-5300","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2,24]]},"published":{"date-parts":[[2026,2,24]]}}}